The impact of a novel herbal Shirazi Thymus Vulgaris on primary dysmenorrhea in comparison to the classical chemical ibuprofen

Journal of Research in Medical Sciences

Volumn 17, Issue 7, 2012, Pages 668-670

  Direkvand Moghadam, Ashraf ^a   Khosravi, Afra ^a  

^a ILAM UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Ibuprofen; Primary dysmenorrheal; Shirazithymus vulgaris

Indexed keywords

BRONCHO T.D; CARVACROL; HERBACEOUS AGENT; IBUPROFEN; SHIRAZI THYMUS VULGARIS; SPASMOLYTIC AGENT; THYMOL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONTROLLED STUDY; DIARRHEA; DISEASE SEVERITY; DYSMENORRHEA; FATIGUE; FEMALE; HEADACHE; HUMAN; LOW BACK PAIN; MAJOR CLINICAL STUDY; NAUSEA; PAIN ASSESSMENT; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; THYME; VISUAL ANALOG SCALE; VOMITING; ZATARIA MULTIFLORA;

EID: 84866760275     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. EspínLópez L, Carrillo Verdejo E, González Javier F, Ordoñana Martín JR, Gómez-Amor J. Incidence of anovulatory menstrual cycles among dysmenorrheic and non-non-dysmenorrheic [corrected] women: effects on symptomatology and mood. Psicothema 2010;22:654-8.
2. Morrison BW, Daniels SE, Kotey P, Cantu N, Seidenberg B. Rofecoxib, a specific cyclooxygenase-2 inhibitor, in primary dysmenorrhea: a randomized controlled trial. ObstetGynecol 1999;94:504-8.
3. French L. Dysmenorrhea in adolescents: diagnosis and treatment. Paediatr Drugs 2008;10:1-7.
4. Lethaby A, Augood C, Duckitt K, Farquhar C. Nonsteroidal antiinflammatory drugs for heavy menstrual bleeding. Cochrane Database Syst Rev 2007: CD000400.
5. Nahid K, Fariborz M, Ataolah G, Solokian S. The effect of an Iranian herbal drug on primary dysmenorrhea: Aclinical controlled trial.J Midwifery Womens Health 2009;54:401-4.
6. Hillen TI, Grbavac SL, Johnston PJ, Straton JA, Keogh JM. Primary dysmenorrhea in young Western Australian women: prevalence, impact, and knowledge of treatment. J Adolesc Health 1999;25:40-5.
7. Burnett MA, Antao V, Black A, Feldman K, Grenville A, Lea R, et al. Prevalence of primary dysmenorrhea in Canada. J ObstetGynaecol Can 2005;27:765-70.
8. Yamaki K, Kim D-H, Ryu N, Kim YP, Shin KH, Ohuchi K. Effects of naturally occurring are flavones on prostaglandin E2 production. Planta Med 2002;68:97-100.
9. Doty E, Attaran M. Managing primary dysmenorrhea. J PediatrAdolescGynecol 2006;19:341-4.
10. Iravani M. Clinical effects of Zatariamultifloraessential oil on primary dysmenorrhea. JMedPlants 2009;8:54-60.
11. Kitajima J, Ishikawa T, Urabe A. A new hydroxyjasmoneglucoside and its related compounds from the leaf of thyme. Chem Pharm Bull (Tokyo) 2004;52:1013-4.
12. Begrow F, Engelbertz J, Feistel B, Lehnfeld R, Bauer K, Verspohl EJ. Impact of thymol in thyme extracts on their antispasmodic action and ciliary clearance. Planta Med2010;76:311-8.
13. Meister A, Bernhardt G, Christoffel V, Buschauer A. Antispasmodic activity of Thymus vulgaris extract on the isolated guinea-pig trachea:discrimination between drug and ethanol effects. Planta Med 1999; 65:512-6.
14. Lefebvre G, Pinsonneault O, Antao V, Black A, Burnett M, Feldman K, et al. Primary dysmenorrhea consensus guideline. J ObstetGynaecol Can 2005;27:1117-46.
15. Marjoribanks J, Proctor M, Farquhar C, Sangkomkamhang US, Derks RS. Nonsteroidal anti-inflammatory drugs for primary dysmenorrhoea. Cochrane Database Syst Rev2009;2:1-10.
16. Doulatian M, Mirabi P, Mojab F, Alavi Majd H. Effects of Valeriana Officinalis on the severity of dysmenorrheal symptoms. J ReprodInfertil 2010;10:253-9.